Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Pattern is back

<< Previous

Bullboard Posts

Next >>

Comment by Biobobon Apr 21, 2022 3:04pm

79 Views

Post# 34621426

RE:Pattern is back

Yep that's waht occurs when an old fart holds a big chunk of Th and that his new 20 somthing broker dictch the stock.. to buy a good 30 PE ketchup company instead... whatever...

<< Previous

Bullboard Posts

Next >>

Increasing summer travel could see these airline stocks soar